• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硅涂层的果胶酸钙珠用于结肠递药。

Silica-coated calcium pectinate beads for colonic drug delivery.

机构信息

Department of Pharmaceutical Technology, School of Pharmacy, Université de Bourgogne, Dijon, France.

出版信息

Acta Biomater. 2013 Apr;9(4):6218-25. doi: 10.1016/j.actbio.2012.11.031. Epub 2012 Dec 3.

DOI:10.1016/j.actbio.2012.11.031
PMID:23219846
Abstract

The aim of this work is to develop novel organic-inorganic hybrid beads for colonic drug delivery. For this purpose, calcium pectinate beads with theophylline are prepared by a cross-linking reaction between amidated low-methoxyl pectin and calcium ions. The beads are then covered with silica, starting from tetraethyoxysilane (TEOS), by a sol-gel process. The influence of TEOS concentration (0.25, 0.50, 0.75 and 1.00 M) during the process is studied in order to modulate the thickness of the silica layer around the pectinate beads and thus to control the drug release. The interactions between the silica coating and the organic beads are weak according to the physicochemical characterizations. A good correlation between physicochemical and in-vitro dissolution tests is observed. At concentrations of TEOS beyond 0.25 M, the silica layer is thick enough to act as a barrier to water uptake and to reduce the swelling ratio of the beads. The drug release is also delayed. Silica-coated pectinate beads are promising candidates for sustained drug delivery systems.

摘要

本工作旨在开发用于结肠药物传递的新型有机-无机杂化珠。为此,通过酰胺化低甲氧基果胶和钙离子之间的交联反应制备含有茶碱的钙果胶珠。然后,通过溶胶-凝胶法从四乙氧基硅烷(TEOS)开始在珠上覆盖二氧化硅。研究了过程中 TEOS 浓度(0.25、0.50、0.75 和 1.00 M)的影响,以调节围绕果胶珠的二氧化硅层的厚度,从而控制药物释放。根据物理化学特性,二氧化硅涂层与有机珠之间的相互作用较弱。观察到物理化学和体外溶解测试之间的良好相关性。在 TEOS 浓度超过 0.25 M 的情况下,二氧化硅层足够厚,可以作为阻挡水吸收的屏障,并降低珠的溶胀比。药物释放也被延迟。二氧化硅涂层的果胶珠是用于持续药物传递系统的有前途的候选物。

相似文献

1
Silica-coated calcium pectinate beads for colonic drug delivery.硅涂层的果胶酸钙珠用于结肠递药。
Acta Biomater. 2013 Apr;9(4):6218-25. doi: 10.1016/j.actbio.2012.11.031. Epub 2012 Dec 3.
2
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery.交联剂类型和壳聚糖含量对用于结肠定位药物传递的果胶-壳聚糖珠性能的影响。
Drug Dev Ind Pharm. 2012 Sep;38(9):1142-51. doi: 10.3109/03639045.2011.641566. Epub 2011 Dec 23.
3
Zinc-pectinate beads as an in vivo self-assembling system for pulsatile drug delivery.锌-果胶珠作为体内自组装体系用于脉冲药物释放。
Int J Pharm. 2011 Jul 29;414(1-2):28-34. doi: 10.1016/j.ijpharm.2011.04.059. Epub 2011 May 12.
4
Silica-coated calcium pectinate formulations for controlling carbendazim release: water and soil release studies.载硅钙交联果胶的苯菌灵控释制剂:水和土壤释放研究。
J Environ Sci Health B. 2021;56(7):613-622. doi: 10.1080/03601234.2021.1927603. Epub 2021 May 17.
5
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery.用于结肠给药的肠溶果胶酸钙微球的研制。
Eur J Pharm Biopharm. 2008 Jun;69(2):508-18. doi: 10.1016/j.ejpb.2007.12.004. Epub 2007 Dec 15.
6
Development of polysaccharide gel-coated pellets for oral administration: swelling and release behavior of calcium pectinate gel.用于口服给药的多糖凝胶包衣微丸的研制:果胶酸钙凝胶的溶胀和释放行为
AAPS PharmSciTech. 2007 Sep 28;8(3):E79. doi: 10.1208/pt0803079.
7
Preparation and release characteristics of mesalazine loaded calcium pectin-silica gel beads based on callus cultures pectins for colon-targeted drug delivery.基于愈伤组织培养的果胶制备和释放特性的载柳氮磺胺吡啶钙果胶-硅凝胶珠用于结肠定位给药。
Int J Biol Macromol. 2018 Dec;120(Pt B):2225-2233. doi: 10.1016/j.ijbiomac.2018.07.078. Epub 2018 Jul 20.
8
Pectin-silica gels as matrices for controlled drug release in gastrointestinal tract.果胶-硅凝胶作为胃肠道内控释药物的基质。
Carbohydr Polym. 2017 Feb 10;157:9-20. doi: 10.1016/j.carbpol.2016.09.048. Epub 2016 Sep 16.
9
Influence of low methoxyl pectin gel textures and in vitro release of rutin from calcium pectinate beads.低甲氧基果胶凝胶质地和芦丁从果胶酸钙珠中体外释放的影响。
Carbohydr Polym. 2013 Sep 12;97(2):335-42. doi: 10.1016/j.carbpol.2013.04.091. Epub 2013 May 9.
10
Colonic drug delivery: influence of cross-linking agent on pectin beads properties and role of the shell capsule type.结肠给药:交联剂对果胶微珠性质的影响及肠溶胶囊类型的作用
Drug Dev Ind Pharm. 2006 Aug;32(7):847-55. doi: 10.1080/03639040500536718.

引用本文的文献

1
Pectin hydrogels for controlled drug release: Recent developments and future prospects.用于控制药物释放的果胶水凝胶:最新进展与未来展望
Saudi Pharm J. 2024 Apr;32(4):102002. doi: 10.1016/j.jsps.2024.102002. Epub 2024 Feb 24.
2
Chitosan and Pectin Hydrogels for Tissue Engineering and In Vitro Modeling.用于组织工程和体外建模的壳聚糖和果胶水凝胶
Gels. 2023 Feb 4;9(2):132. doi: 10.3390/gels9020132.
3
Fibrin-Rhamnogalacturonan I Composite Gel for Therapeutic Enzyme Delivery to Intestinal Tumors.纤维蛋白-鼠李半乳糖醛酸聚糖 I 复合凝胶用于治疗肠道肿瘤的酶传递。
Int J Mol Sci. 2023 Jan 4;24(2):926. doi: 10.3390/ijms24020926.
4
Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release.用于靶向药物释放的基于鼠李半乳糖醛酸聚糖-I的微胶囊
PLoS One. 2016 Dec 19;11(12):e0168050. doi: 10.1371/journal.pone.0168050. eCollection 2016.
5
Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.使用基于生理学的药代动力学模型优化纳米药物的药代动力学
Br J Pharmacol. 2014 Sep;171(17):3963-79. doi: 10.1111/bph.12604. Epub 2014 Jul 2.